The announcement follows the company’s recent 350 crore investment in India, to accelerate R&D, manufacturing and sustainable innovation
Siegwerk has announced its strategic entry into the pharmaceutical packaging segment in India, reinforcing its commitment to consumer safety. This strategic move directly addresses rising global concerns regarding ink migration and significantly enhances product safety for consumers in India. With this move, the company aims to redefine safety standards in packaging through the launch of a dedicated range of mineral oil-free inks. Mineral oils have earned global disrepute for their toxicological profile, often linked with severe impact on human health.
“As a company deeply committed to safety and sustainability, Siegwerk believes that the pharmaceutical industry must take a holistic view, recognizing that packaging materials play a critical role in ensuring product integrity,” said Ashish Pradhan, President, Siegwerk Asia. “With our mineral oil-free ink systems, we are providing pharma brands in India with a safer, compliant alternative that protects consumers and aligns with evolving global standards.”
The company sees significant long-term potential in the pharmaceutical segment in India, where demand for high-quality, export-compliant packaging is accelerating. The announcement comes after Siegwerk’s Rs 350 crore investment aimed not just to meet current regulatory benchmarks, but to go beyond compliance by pioneering next-generation, safe and sustainable ink solutions that anticipate the needs of tomorrow’s packaging industry. This foray aligns with Siegwerk’s broader vision of driving safer, more sustainable packaging solutions globally, especially in high-stakes sectors like pharmaceuticals and healthcare.
